Evaluating the Safety of an Educational Deprescribing Intervention: Lessons from the Optimize Trial.

Autor: Boyd CM; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cyboyd@jhmi.edu.; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Veterans Affairs Medical Center, Durham, NC, USA. cyboyd@jhmi.edu., Shetterly SM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Powers JD; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Weffald LA; Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA., Green AR; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sheehan OC; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Royal College of Surgeons in Ireland, Dublin, Ireland., Reeve E; Faculty of Pharmacy and Pharmaceutical Sciences, Centre for Medicine Use and Safety, Monash University, Melbourne, VIC, Australia.; Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Science, University of South Australia, Adelaide, SA, Australia., Drace ML; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Norton JD; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Maiyani M; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Gleason KS; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Sawyer JK; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Maciejewski ML; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Veterans Affairs Medical Center, Durham, NC, USA.; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Wolff JL; Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA., Kraus C; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Bayliss EA; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Publikováno v: Drugs & aging [Drugs Aging] 2024 Jan; Vol. 41 (1), pp. 45-54. Date of Electronic Publication: 2023 Nov 20.

Intervention design in cognitively impaired populations-Lessons learned from the OPTIMIZE deprescribing pragmatic trial.

Autor: Sheehan OC; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Geriatric Medicine, Royal College of Surgeons in Ireland, Connolly Hospital, Dublin, Ireland., Gleason KS; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Bayliss EA; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA.; Department of Family Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA., Green AR; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Drace ML; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Norton J; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Reeve E; Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Science, University of South Australia, Adelaide, Australia.; Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Australia., Shetterly SM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Weffald LA; Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, Colorado, USA., Sawyer JK; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Maciejewski ML; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Veterans Affairs Medical Center, Durham, North Carolina, USA.; Department of Population Health Sciences, Duke University Medical Center, Durham, North Carolina, USA., Kraus C; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Maiyani M; Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, USA., Wolff J; School of Public Health, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Boyd CM; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; School of Public Health, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Publikováno v: Journal of the American Geriatrics Society [J Am Geriatr Soc] 2023 Mar; Vol. 71 (3), pp. 774-784. Date of Electronic Publication: 2022 Dec 12.

Perspectives on Deprescribing Communication in Primary Care.

Autor: Green AR; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. ariel@jhmi.edu., Boyd CM; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Gleason KS; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Wright L; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Kraus CR; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Bedoy R; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Sanchez B; University of Colorado School of Medicine, Aurora, CO, USA., Norton J; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Sheehan OC; Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wolff JL; Roger C. Lipitz Center for Integrated Health Care, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Reeve E; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, SA, Adelaide, Australia., Maciejewski ML; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham Veterans Affairs Medical Center, Durham, NC, USA.; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Weffald LA; Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA., Bayliss EA; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Publikováno v: Journal of general internal medicine [J Gen Intern Med] 2021 Apr; Vol. 36 (4), pp. 1122.

The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.

Autor: Bayliss EA; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA. Elizabeth.Bayliss@kp.org.; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA. Elizabeth.Bayliss@kp.org., Shetterly SM; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Drace ML; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Norton J; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Green AR; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Reeve E; Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.; Geriatric Medicine Research, Faculty of Medicine, and College of Pharmacy, Dalhousie University and Nova Scotia Health Authority, Halifax, NS, Canada., Weffald LA; Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA., Wright L; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Maciejewski ML; Durham Center of Innovation to Accelerate Discovery and Practice Transformation (ADAPT), Durham, Veterans Affairs Medical Center, Durham, NC, USA.; Department of Population Health Sciences, Duke University Medical Center, Durham, NC, USA., Sheehan OC; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wolff JL; School of Public Health, Johns Hopkins School of Medicine, Baltimore, MD, USA., Gleason KS; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Kraus C; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Maiyani M; Institute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA., Du Vall M; Department of Clinical Pharmacy, Kaiser Permanente Colorado, Aurora, CO, USA., Boyd CM; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Trials [Trials] 2020 Jun 18; Vol. 21 (1), pp. 542. Date of Electronic Publication: 2020 Jun 18.

Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.

Autor: Green AR; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th Floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA. ariel@jhmi.edu., Reifler LM; Institute for Health Research, Kaiser Permanente Colorado, 10065 E. Harvard Ave. Suite 300, Denver, CO, 80207, USA., Boyd CM; Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Mason F. Lord Center Tower, 7th Floor, 5200 Eastern Avenue, Baltimore, MD, 21224, USA.; Department of Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Weffald LA; Institute for Health Research, Kaiser Permanente Colorado, 10065 E. Harvard Ave. Suite 300, Denver, CO, 80207, USA.; University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA., Bayliss EA; Institute for Health Research, Kaiser Permanente Colorado, 10065 E. Harvard Ave. Suite 300, Denver, CO, 80207, USA. elizabeth.bayliss@kp.org.; Department of Family Medicine, University of Colorado School of Medicine, Aurora, CO, USA. elizabeth.bayliss@kp.org.

Publikováno v: Drugs & aging [Drugs Aging] 2018 Mar; Vol. 35 (3), pp. 223-232.